regulus therapeutics inc
(RGLS:NASDAQ SE Consolidated Large Cap)
As of 8:10 PM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).
Key Executives - regulus therapeutics inc (RGLS)
| Name | Board Relationships | Title | Age |
| Kleanthis G. Xanthopoulos Ph.D. | 142 Relationships | Chief Executive Officer, President and Director | 54 |
| Garry E. Menzel Ph.D. | No Relationships | Chief Operating Officer and Executive Vice President of Finance | 48 |
Board Members - regulus therapeutics inc (RGLS)
| Name | Board Relationships | Primary Company | Age |
| John M. Maraganore Ph.D. | 182 Relationships | Alnylam Pharmaceuticals, Inc. | 49 |
| Kleanthis G. Xanthopoulos Ph.D. | 142 Relationships | Regulus Therapeutics Inc. | 54 |
| David Baltimore Ph.D. | 119 Relationships | Ariad Pharmaceuticals Inc. | 74 |
| B. Lynne Parshall Esq., J.D. | 50 Relationships | Isis Pharmaceuticals, Inc. | 56 |
| Stelios Papadopoulos Ph.D. | 104 Relationships | Exelixis, Inc. | 64 |
Executive Committees* - regulus therapeutics inc (RGLS)
| Committee Name | Chairperson | Board Relationships | Members |
| Audit Committee | B. Lynne Parshall Esq., J.D. | 50 Relationships | 3 Executives |
| Compensation Committee | John M. Maraganore Ph.D. | 182 Relationships | 2 Executives |
| Nominating Committee | Stelios Papadopoulos Ph.D. | 104 Relationships | 2 Executives |
| Corporate Governance Committee | Stelios Papadopoulos Ph.D. | 104 Relationships | 2 Executives |
| Advisory Board | David Baltimore Ph.D. | 119 Relationships | 5 Executives |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| RGLS:US | $7.14 USD | +0.09 |  |
| Company | Last | Change |
| Arrowhead Research Corp | $2.18 USD | -0.03 |
| Benitec Biopharma Ltd | A$0.02 AUD | 0.00 |
| Enzon Pharmaceuticals Inc | $3.07 USD | -0.07 |
| Silence Therapeutics PLC | 197.00 GBp | -8.00 |
| Tekmira Pharmaceuticals Corp | C$4.85 CAD | -0.05 |
| View Industry Companies | ||
Industry Analysis
RGLS
Industry Average
| Valuation | RGLS | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 20.1x |
|
| Price/Book | 4.5x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 12.0x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact REGULUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
